Continuing Education Event – Supporting Recovery through Adherence to MAT and Avoidance of High Risk Meds – Webinar – 10/20/21
Recently, there has been a focus on the benefits of medications for opioid use disorder, especially buprenorphine and methadone, which can reduce a person’s risk for overdose and death while supporting their long-term recovery. However, there has been minimal attention paid to adherence to these medications and avoidance of other medications that people with substance use disorders are often prescribed that can put a person’s recovery at risk. In this presentation we will discuss strategies to support adherence to medications for addiction treatment (MAT). We will also review common symptoms present in people with SUDs that can lead to high risk prescriptions and how to best support someone’s recovery while managing those symptoms.
- List 3 concrete ways to help patients take their MAT as directed.
- Describe 3 methods to improve sleep without using sedative-hypnotic medications.
- Explain 3 strategies for reducing anxiety without using benzodiazepines.
Recovery Centers of America has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7002. Programs that do not qualify for NBCC credit are clearly identified. Recovery Centers of America is solely responsible for all aspects of the programs. This course qualifies for 2 credit hours.
Dr. Heidi Ginter
Chief Medical Director
Dr. Heidi Ginter, MD, FASAM has nearly two decades of experience working in the addiction treatment field, is Board Certified in Addiction Medicine, and is a prominent voice in medication-assisted treatment (MAT). MAT, the use of FDA-approved medications in combination with counseling and behavioral therapies, is widely considered to be an effective tool in battling addiction to opioids and other drugs.
Dr. Ginter graduated from Yale University and earned her doctorate at the University of Maryland School of Medicine. She has lectured extensively on MAT and opioid dependence. Dr. Ginter started her career as a family doctor for underserved populations and eventually found a passion for helping pregnant women struggling with addiction. Most recently, she was the Regional Medical Director and Chief Medical Officer for an outpatient addiction treatment provider with 16 sites in Massachusetts, Maine, New Hampshire and Connecticut.